Skip to main content
. 2026 Jul 10;18(14):2251. doi: 10.3390/nu18142251
Abbreviation Definition
AE adverse event
AKI acute kidney injury
ALT alanine aminotransferase
AST aspartate aminotransferase
BID twice daily
BMI body mass index
CI confidence interval
DB double blind
DBP diastolic blood pressure
EFSA European Food Safety Authority
FPG fasting plasma glucose
GRADE Grading of Recommendations Assessment, Development and Evaluation
HbA1c glycated hemoglobin
HDL-C high-density lipoprotein cholesterol
HOMA-IR homeostatic model assessment of insulin resistance
LDL-C low-density lipoprotein cholesterol
MIB-626 microcrystalline β-nicotinamide mononucleotide formulation
NAD+ nicotinamide adenine dinucleotide
NMN nicotinamide mononucleotide
NR not reported
OR odds ratio
PC Placebo controlled
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
QD once daily
RCT randomized controlled trial
RD risk difference
RoB risk of bias
SAE serious adverse event
SBP systolic blood pressure
SMD standardized mean difference
T2DM type 2 diabetes mellitus
TC total cholesterol
TG triglyceride